Published in Heart Rhythm on September 19, 2009
Gender differences in accessory connections location: an Israeli study. J Interv Card Electrophysiol (2012) 0.75
Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med (2001) 4.46
Supraventricular tachycardia. N Engl J Med (1995) 2.85
A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation (1993) 2.03
Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). N Engl J Med (1987) 1.35
The natural history of Wolff-Parkinson-White syndrome in 228 military aviators: a long-term follow-up of 22 years. Am Heart J (2001) 1.13
[Prevalence and course of Wolf-Parkinson-White syndrome in a population of 138,048 subjects]. Ann Med Interne (Paris) (1985) 1.09
Electrophysiologic characteristics and radiofrequency catheter ablation in children with Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol (2006) 0.92
[The prevalence of the Wolff-Parkinson-White syndrome in a population of 116,542 young males]. G Ital Cardiol (1995) 0.90
Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome. J Electrocardiol (2001) 0.85
Familial preexcitation and pseudo-preexcitation syndromes. J Cardiovasc Electrophysiol (2006) 0.81
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol (2004) 3.44
Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res (2004) 3.30
Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol (2012) 3.12
J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol (2008) 2.87
Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol (1985) (2007) 2.52
Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol (2006) 2.48
Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol (2004) 2.44
Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng (2004) 2.42
Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med (2010) 2.14
Funding source and author affiliation in TASER research are strongly associated with a conclusion of device safety. Am Heart J (2011) 2.04
Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol (2003) 2.01
Success rates in pediatric WPW ablation are improved with 3-dimensional mapping systems compared with fluoroscopy alone: a multicenter study. J Cardiovasc Electrophysiol (2015) 2.01
Myotube assembly on nanofibrous and micropatterned polymers. Nano Lett (2006) 2.00
Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm (2009) 2.00
Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm (2010) 1.89
Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm (2006) 1.86
Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol (2011) 1.85
Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol (2007) 1.84
Regional left atrial voltage in patients with atrial fibrillation. Heart Rhythm (2006) 1.84
Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol (2009) 1.83
Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm (2007) 1.82
Tissue structure and connexin expression of canine pulmonary veins. Cardiovasc Res (2002) 1.77
Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation (2003) 1.73
Influence of left ventricular lead location on outcomes in the COMPANION study. J Cardiovasc Electrophysiol (2009) 1.72
Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med (2009) 1.71
Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm (2009) 1.59
Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease. Heart Rhythm (2008) 1.56
Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1. Cardiovasc Res (2013) 1.55
Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience. Heart Rhythm (2012) 1.55
Safety profiles and lesion size of different radiofrequency ablation technologies: a comparison of large tip, open and closed irrigation catheters. J Cardiovasc Electrophysiol (2008) 1.51
Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey. Heart Rhythm (2012) 1.49
Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm (2012) 1.49
Postresuscitation stunning: postfibrillatory myocardial dysfunction caused by reduced myofilament Ca2+ responsiveness after ventricular fibrillation-induced myocyte Ca2+ overload. J Cardiovasc Electrophysiol (2002) 1.48
Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng (2006) 1.46
Time and temperature profile of catheter cryoablation of right septal and free wall accessory pathways in children. J Cardiovasc Electrophysiol (2007) 1.44
Rhythm and conduction disturbances at midterm follow-up after the ross procedure in infants, children, and young adults. Ann Thorac Surg (2008) 1.44
Prospective observations in the clinical and electrophysiological characteristics of intra-isthmus reentry. J Cardiovasc Electrophysiol (2010) 1.43
Elevated pulmonary artery systolic pressures are associated with a lower risk of atrial fibrillation following lung transplantation. J Electrocardiol (2012) 1.43
Etiologic considerations in the patient with syncope and an apparently normal heart. Arch Intern Med (2003) 1.43
Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J (2007) 1.42
Predictors of axillary vein location for vascular access during pacemaker and defibrillator lead implantation. Pacing Clin Electrophysiol (2011) 1.42
The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol (2011) 1.39
Trainee inexperience is associated with longer procedure times but no increase in complications for cardiac device implantation. Heart Rhythm (2013) 1.39
Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation (2006) 1.38
Incident atrial fibrillation among Asians, Hispanics, blacks, and whites. Circulation (2013) 1.35
Racial differences in atrial fibrillation prevalence and left atrial size. Am J Med (2010) 1.32
Diastolic dysfunction after mediastinal irradiation. Am Heart J (2005) 1.28
Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2009) 1.21
Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study. Ann Intern Med (2013) 1.21
Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. Am J Physiol Heart Circ Physiol (2006) 1.20
The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials (2010) 1.20
Increases in P-wave dispersion predict postoperative atrial fibrillation after coronary artery bypass graft surgery. Anesth Analg (2004) 1.19
Atrial flutter: a review of its history, mechanisms, clinical features, and current therapy. Curr Probl Cardiol (2005) 1.18
Cardiac conduction is required to preserve cardiac chamber morphology. Proc Natl Acad Sci U S A (2010) 1.17
The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials (2008) 1.17